OpenAlex
PricingAboutJobs
Log inGet started
Work

Differentiating sodium-glucose co-transporter-2 inhibitors in development for the treatment of type 2 diabetes mellitus

HTML

Year: 2013
Type: review
Source: Expert Opinion on Investigational Drugs
DOI: 10.1517/13543784.2013.774372
Authors: William N Washburn, Simon M Poucher
Institutions: Bristol-Myers Squibb (United States), AstraZeneca (United Kingdom)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: SGLT2 inhibitors, type 2 diabetes, SGLT1, glycosuria, renal glucose reabsorption, glycemic control, beta-cell function, insulin sensitivity, weight loss, blood pressure reduction, drug safety, antidiabetic drug combination, drug development
SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company
OpenAlex ID: W2007832417
FWCI: 1.371
Cites: 84
Cited by: 87
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security